Literature DB >> 27490782

The role of short-chain fatty acid on blood pressure regulation.

Junki Miyamoto1, Mayu Kasubuchi, Akira Nakajima, Junichiro Irie, Hiroshi Itoh, Ikuo Kimura.   

Abstract

PURPOSE OF REVIEW: The gut microbiota and its metabolites have been implicated in the regulation of host physiological functions such as inflammatory and metabolic responses. The short-chain fatty acid (SCFA) receptor is expressed in the kidney and blood vessels as well, and has been reported to function as a regulator of blood pressure (BP). This review highlights the role of SCFAs derived from gut microbial fermentation in the regulation of BP. RECENT
FINDINGS: Olfactory receptor 78 (Olfr78) is a member of the G-protein-coupled receptor family, and it plays a key role as a chemosensor in various tissues. Both Olfr78 and G protein-coupled receptor 41 (GPR41) are expressed in smooth muscle cells of blood vessels and they recognize SCFAs. Oral administration of SCFAs was found to change BP in vivo, an effect that was altered in Olfr78 and GPR41-deficient mice.
SUMMARY: The regulation of BP via SCFA receptors has provided new insights into the interactions between the gut microbiota and BP control systems. We summarize these interactions and describe their contributions to a novel pathway involved in BP regulation. These recent findings could open new avenues for the development of therapeutic strategies for the treatment of cardiovascular diseases.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 27490782     DOI: 10.1097/MNH.0000000000000246

Source DB:  PubMed          Journal:  Curr Opin Nephrol Hypertens        ISSN: 1062-4821            Impact factor:   2.894


  30 in total

Review 1.  Microbial modulation of cardiovascular disease.

Authors:  J Mark Brown; Stanley L Hazen
Journal:  Nat Rev Microbiol       Date:  2018-01-08       Impact factor: 60.633

Review 2.  Antihypertensive Effects of Probiotics.

Authors:  Iñaki Robles-Vera; Marta Toral; Miguel Romero; Rosario Jiménez; Manuel Sánchez; Francisco Pérez-Vizcaíno; Juan Duarte
Journal:  Curr Hypertens Rep       Date:  2017-04       Impact factor: 5.369

3.  Exploration of the effects of altitude change on bacteria and fungi in the rumen of yak (Bos grunniens).

Authors:  Dongwang Wu; Paramintra Vinitchaikul; Mingyue Deng; Guangrong Zhang; Liyuan Sun; Hanxue Wang; Xiao Gou; Huaming Mao; Shuli Yang
Journal:  Arch Microbiol       Date:  2020-10-17       Impact factor: 2.552

Review 4.  Short-Chain Fatty Acid Receptors and Blood Pressure Regulation: Council on Hypertension Mid-Career Award for Research Excellence 2021.

Authors:  Jiaojiao Xu; Brittni N Moore; Jennifer L Pluznick
Journal:  Hypertension       Date:  2022-08-01       Impact factor: 9.897

5.  Gut microbiota is associated with dietary intake and metabolic markers in healthy individuals.

Authors:  Line Gaundal; Mari C W Myhrstad; Ida Rud; Terje Gjøvaag; Marte G Byfuglien; Kjetil Retterstøl; Kirsten B Holven; Stine M Ulven; Vibeke H Telle-Hansen
Journal:  Food Nutr Res       Date:  2022-06-23       Impact factor: 3.221

6.  Attenuation of Microbiotal Dysbiosis and Hypertension in a CRISPR/Cas9 Gene Ablation Rat Model of GPER1.

Authors:  Harshal Waghulde; Xi Cheng; Sarah Galla; Blair Mell; Jingwei Cai; Shondra M Pruett-Miller; Guillermo Vazquez; Andrew Patterson; Matam Vijay Kumar; Bina Joe
Journal:  Hypertension       Date:  2018-11       Impact factor: 10.190

7.  Chitosan alleviated menopausal symptoms and modulated the gut microbiota in estrogen-deficient rats.

Authors:  Xuangao Wu; Min Jung Kim; Hye Jeong Yang; Sunmin Park
Journal:  Eur J Nutr       Date:  2020-09-10       Impact factor: 5.614

Review 8.  Gut Microbiota-Derived Short-Chain Fatty Acids Facilitate Microbiota:Host Cross talk and Modulate Obesity and Hypertension.

Authors:  Haley B Overby; Jane F Ferguson
Journal:  Curr Hypertens Rep       Date:  2021-02-03       Impact factor: 5.369

9.  Human Stool Metabolome Differs upon 24 h Blood Pressure Levels and Blood Pressure Dipping Status: A Prospective Longitudinal Study.

Authors:  Justine Huart; Arianna Cirillo; Bernard Taminiau; Julie Descy; Annie Saint-Remy; Georges Daube; Jean-Marie Krzesinski; Pierrette Melin; Pascal de Tullio; François Jouret
Journal:  Metabolites       Date:  2021-04-29

10.  Genetic Variants Associated With Uncontrolled Blood Pressure on Thiazide Diuretic/β-Blocker Combination Therapy in the PEAR (Pharmacogenomic Evaluation of Antihypertensive Responses) and INVEST (International Verapamil-SR Trandolapril Study) Trials.

Authors:  Oyunbileg Magvanjav; Yan Gong; Caitrin W McDonough; Arlene B Chapman; Stephen T Turner; John G Gums; Kent R Bailey; Eric Boerwinkle; Amber L Beitelshees; Toshihiro Tanaka; Michiaki Kubo; Carl J Pepine; Rhonda M Cooper-DeHoff; Julie A Johnson
Journal:  J Am Heart Assoc       Date:  2017-11-02       Impact factor: 5.501

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.